SLC24A4
geneOn this page
Also known as NCKX4
Summary
SLC24A4 (solute carrier family 24 member 4, HGNC:10978) is a protein-coding gene on chromosome 14q32.12, encoding Sodium/potassium/calcium exchanger 4 (Q8NFF2). Calcium, potassium:sodium antiporter that transports 1 Ca(2+) and 1 K(+) in exchange for 4 Na(+).
This gene encodes a sodium/potassium/calcium exchange protein. The encoded antiporter transports one calcium and one potassium ion in exchange for four sodium ions and has been implicated in amelogenesis and enamel maturation. Certain variants in this gene have been associated with skin, hair, and eye pigmentation, while other variants have been identified in people with hypomaturation-type amelogenesis imperfecta.
Source: NCBI Gene 123041 — RefSeq curated summary.
At a glance
- Gene–disease (curated): amelogenesis imperfecta hypomaturation type 2A5 (Strong, GenCC) — +2 more curated relationships
- GWAS associations: 38
- Clinical variants (ClinVar): 186 total — 5 pathogenic
- Phenotypes (HPO): 7
- Druggable target: yes
- MANE Select transcript:
NM_153646
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10978 |
| Approved symbol | SLC24A4 |
| Name | solute carrier family 24 member 4 |
| Location | 14q32.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NCKX4 |
| Ensembl gene | ENSG00000140090 |
| Ensembl biotype | protein_coding |
| OMIM | 609840 |
| Entrez | 123041 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000393265, ENST00000525557, ENST00000526482, ENST00000531433, ENST00000532405, ENST00000554461, ENST00000554925, ENST00000556739, ENST00000676001
RefSeq mRNA: 5 — MANE Select: NM_153646
NM_001378620, NM_001425254, NM_153646, NM_153647, NM_153648
CCDS: CCDS45155, CCDS45156, CCDS9903
Canonical transcript exons
ENST00000532405 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001704568 | 92442089 | 92442173 |
| ENSE00001758281 | 92443400 | 92443474 |
| ENSE00001791793 | 92442713 | 92442816 |
| ENSE00002191205 | 92323165 | 92323960 |
| ENSE00003489845 | 92445317 | 92445342 |
| ENSE00003501117 | 92439335 | 92439409 |
| ENSE00003506793 | 92486666 | 92486780 |
| ENSE00003564475 | 92453900 | 92454069 |
| ENSE00003570997 | 92325868 | 92325978 |
| ENSE00003601716 | 92492175 | 92492240 |
| ENSE00003620417 | 92433912 | 92433988 |
| ENSE00003624578 | 92449074 | 92449216 |
| ENSE00003632040 | 92491665 | 92491777 |
| ENSE00003662483 | 92482680 | 92482846 |
| ENSE00003670862 | 92447371 | 92447424 |
| ENSE00003682560 | 92456404 | 92456608 |
| ENSE00003746464 | 92493476 | 92501481 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 89.47.
FANTOM5 (CAGE): breadth broad, TPM avg 1.3040 / max 86.3141, expressed in 219 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 141085 | 1.2744 | 218 |
| 141084 | 0.0296 | 17 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 89.47 | gold quality |
| leukocyte | CL:0000738 | 88.87 | gold quality |
| primary visual cortex | UBERON:0002436 | 83.73 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 83.23 | gold quality |
| sural nerve | UBERON:0015488 | 83.02 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 82.60 | gold quality |
| blood | UBERON:0000178 | 81.63 | gold quality |
| granulocyte | CL:0000094 | 81.45 | gold quality |
| endothelial cell | CL:0000115 | 79.90 | silver quality |
| occipital lobe | UBERON:0002021 | 79.53 | gold quality |
| buccal mucosa cell | CL:0002336 | 78.81 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.49 | gold quality |
| pons | UBERON:0000988 | 77.18 | gold quality |
| medial globus pallidus | UBERON:0002477 | 76.92 | gold quality |
| globus pallidus | UBERON:0001875 | 75.98 | gold quality |
| tibial nerve | UBERON:0001323 | 74.60 | gold quality |
| postcentral gyrus | UBERON:0002581 | 74.33 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 73.96 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.80 | gold quality |
| right frontal lobe | UBERON:0002810 | 73.61 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.28 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 73.08 | gold quality |
| corpus callosum | UBERON:0002336 | 73.06 | gold quality |
| frontal cortex | UBERON:0001870 | 73.04 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 72.66 | gold quality |
| medulla oblongata | UBERON:0001896 | 72.23 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 72.14 | gold quality |
| midbrain | UBERON:0001891 | 72.02 | gold quality |
| substantia nigra | UBERON:0002038 | 72.01 | gold quality |
| parietal lobe | UBERON:0001872 | 71.89 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-75367 | yes | 64.75 |
| E-GEOD-137537 | yes | 18.07 |
| E-ANND-3 | yes | 4.64 |
| E-GEOD-111727 | no | 212.80 |
| E-CURD-11 | no | 6.46 |
| E-MTAB-5061 | no | 2.24 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
283 targeting SLC24A4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
Literature-anchored findings (GeneRIF, showing 13)
- identification and sequencing, as well as mapping to chromosomal region 14q32 (PMID:12379639)
- IRF4 and SLC24A4 loci are associated with human hair color and skin pigmentation. (PMID:18483556)
- Taken together, these data demonstrate a potentially important role for NCX1 in control of Ca2+ homeostasis and link store depletion via STIM1 directly with NCX activation. (PMID:21126331)
- These findings support a key role for SLC24A4 in calcium transport during enamel formation. (PMID:23375655)
- enamel maturation is dependent upon STIM1 and SLC24A4 function, and that there are important differences in the Ca(2+) transcellular transport systems used by secretory- and maturation-stage ameloblasts. (PMID:24621671)
- Brain DNA methylation in sLC24A4 was associated with pathological Alzheimer disease. (PMID:25365775)
- The expressions of NCX1 and NCKX4 were significantly higher in the patent ductus arteriosus group at both the protein and mRNA levels. (PMID:25500693)
- pigment cells express robust, functional NCKX4 activity (PMID:27093457)
- mutations in SLC24A4 and SLC24A5 are responsible for the phenotypic defects observed in human amylogenesis imperfecta and non-syndromic oculocutaneous albinism patients. (PMID:27129268)
- no significant relation was noted between SLC24A4 rs10498633 and late-onset Alzheimer;s disease risk in neither apolipoprotein E (APOE) epsilon4 carriers nor non-carriers after adjusting for age and gender (PMID:27215332)
- This nonsense sequence variant c.1192C > T (p.Gln398*) is the sixth disease-causing variant in SLC24A4, which extends its mutation spectrum and confirms the role of this gene in the morphogenesis of human tooth enamel. The identified variant highlights the critical role of SLC24A4 in causing a rare Amelogenesis imperfecta (AI) type in humans. (PMID:32380970)
- Association between brown eye colour in rs12913832:GG individuals and SNPs in TYR, TYRP1, and SLC24A4. (PMID:32915910)
- Calmodulin binds and modulates K(+)-dependent Na(+)/Ca(2+)-exchanger isoform 4, NCKX4. (PMID:33199372)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc24a4a | ENSDARG00000015425 |
| danio_rerio | slc24a4b | ENSDARG00000067509 |
| mus_musculus | Slc24a4 | ENSMUSG00000041771 |
| rattus_norvegicus | Slc24a4 | ENSRNOG00000006729 |
| drosophila_melanogaster | CG17167 | FBGN0039941 |
| drosophila_melanogaster | CG12061 | FBGN0040031 |
| drosophila_melanogaster | zyd | FBGN0265767 |
Paralogs (4): SLC24A1 (ENSG00000074621), SLC24A2 (ENSG00000155886), SLC24A3 (ENSG00000185052), SLC24A5 (ENSG00000188467)
Protein
Protein identifiers
Sodium/potassium/calcium exchanger 4 — Q8NFF2 (reviewed: Q8NFF2)
Alternative names: Na(+)/K(+)/Ca(2+)-exchange protein 4, Solute carrier family 24 member 4
All UniProt accessions (3): Q8NFF2, G3V505, H0YCX3
UniProt curated annotations — full annotation on UniProt →
Function. Calcium, potassium:sodium antiporter that transports 1 Ca(2+) and 1 K(+) in exchange for 4 Na(+). Controls the rapid response termination and proper regulation of adaptation in olfactory sensory neurons (OSNs) which subsequently influences how odor information is encoded and perceived. May play a role in calcium transport during amelogenesis.
Subcellular location. Cell membrane. Cytoplasm.
Tissue specificity. Expressed abundantly in all regions of the brain, aorta, lung and thymus. Expressed at lower levels in the stomach and intestine.
Disease relevance. Amelogenesis imperfecta, hypomaturation type, 2A5 (AI2A5) [MIM:615887] A defect of enamel formation. The disorder involves both primary and secondary dentitions. The teeth have a shiny agar jelly appearance and the enamel is softer than normal. Brown pigment is present in middle layers of enamel. The disease is caused by variants affecting the gene represented in this entry.
Polymorphism. Genetic variants in SLC24A4 define the skin/hair/eye pigmentation variation locus 6 (SHEP6) [MIM:210750]. Hair, eye and skin pigmentation are among the most visible examples of human phenotypic variation, with a broad normal range that is subject to substantial geographic stratification. In the case of skin, individuals tend to have lighter pigmentation with increasing distance from the equator. By contrast, the majority of variation in human eye and hair color is found among individuals of European ancestry, with most other human populations fixed for brown eyes and black hair.
Similarity. Belongs to the Ca(2+):cation antiporter (CaCA) (TC 2.A.19) family. SLC24A subfamily.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NFF2-1 | 1 | yes |
| Q8NFF2-2 | 2 | |
| Q8NFF2-3 | 3 | |
| Q8NFF2-4 | 4 |
RefSeq proteins (5): NP_001365549, NP_001412183, NP_705932, NP_705933, NP_705934 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004481 | K/Na/Ca-exchanger | Family |
| IPR004837 | NaCa_Exmemb | Domain |
| IPR044880 | NCX_ion-bd_dom_sf | Homologous_superfamily |
Pfam: PF01699
Catalyzed reactions (Rhea), 1 shown:
- Ca(2+)(out) + K(+)(out) + 4 Na(+)(in) = Ca(2+)(in) + K(+)(in) + 4 Na(+)(out) (RHEA:69967)
UniProt features (43 total): topological domain 11, transmembrane region 10, sequence variant 7, splice variant 4, repeat 2, compositionally biased region 2, glycosylation site 2, sequence conflict 2, signal peptide 1, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NFF2-F1 | 70.84 | 0.16 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 69, 76
Function
Pathways and Gene Ontology
Reactome pathways
8 pathways
| ID | Pathway |
|---|---|
| R-HSA-425561 | Sodium/Calcium exchangers |
| R-HSA-5619055 | Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI) |
| R-HSA-1643685 | Disease |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-425393 | |
| R-HSA-425407 | SLC-mediated transmembrane transport |
| R-HSA-5619102 | SLC transporter disorders |
| R-HSA-5619115 | Disorders of transmembrane transporters |
MSigDB gene sets: 263 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP, GOBP_POTASSIUM_ION_TRANSPORT, GOBP_RESPONSE_TO_NITROGEN_COMPOUND, YAATNRNNNYNATT_UNKNOWN, BENPORATH_ES_WITH_H3K27ME3, GOBP_BEHAVIOR, GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING, TGCACTT_MIR519C_MIR519B_MIR519A, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_PHOTOTRANSDUCTION, TGACCTY_ERR1_Q2, LHX3_01
GO Biological Process (29): monoatomic ion transport (GO:0006811), intracellular calcium ion homeostasis (GO:0006874), phototransduction (GO:0007602), sensory perception of smell (GO:0007608), regulation of G protein-coupled receptor signaling pathway (GO:0008277), response to high light intensity (GO:0009644), positive regulation of gene expression (GO:0010628), olfactory nerve maturation (GO:0021630), sodium ion transmembrane transport (GO:0035725), cone photoresponse recovery (GO:0036368), drinking behavior (GO:0042756), negative regulation of calcium-mediated signaling (GO:0050849), detection of chemical stimulus involved in sensory perception of smell (GO:0050911), calcium ion homeostasis (GO:0055074), enamel mineralization (GO:0070166), calcium ion transmembrane transport (GO:0070588), cellular response to high light intensity (GO:0071486), potassium ion transmembrane transport (GO:0071805), membrane repolarization (GO:0086009), amelogenesis (GO:0097186), calcium ion import across plasma membrane (GO:0098703), regulation of eating behavior (GO:1903998), calcium ion export across plasma membrane (GO:1990034), response to melanocyte-stimulating hormone (GO:1990680), response to odorant (GO:1990834), potassium ion transport (GO:0006813), sodium ion transport (GO:0006814), calcium ion transport (GO:0006816), transmembrane transport (GO:0055085)
GO Molecular Function (6): calcium channel activity (GO:0005262), calmodulin binding (GO:0005516), calcium, potassium:sodium antiporter activity (GO:0008273), symporter activity (GO:0015293), calcium-dependent protein binding (GO:0048306), antiporter activity (GO:0015297)
GO Cellular Component (7): cytoplasm (GO:0005737), plasma membrane (GO:0005886), membrane (GO:0016020), apical plasma membrane (GO:0016324), vesicle (GO:0031982), cone photoreceptor outer segment (GO:0120199), cell periphery (GO:0071944)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Metal ion SLC transporters | 1 |
| SLC transporter disorders | 1 |
| Transport of small molecules | 1 |
| Disorders of transmembrane transporters | 1 |
| Disease | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| monoatomic cation transmembrane transport | 3 |
| cellular anatomical structure | 3 |
| protein binding | 2 |
| secondary active transmembrane transporter activity | 2 |
| transport | 1 |
| intracellular monoatomic cation homeostasis | 1 |
| calcium ion homeostasis | 1 |
| signal transduction | 1 |
| detection of light stimulus | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| regulation of signal transduction | 1 |
| response to light intensity | 1 |
| gene expression | 1 |
| regulation of gene expression | 1 |
| positive regulation of macromolecule biosynthetic process | 1 |
| olfactory nerve development | 1 |
| cranial nerve maturation | 1 |
| sodium ion transport | 1 |
| response to light stimulus | 1 |
| feeding behavior | 1 |
| calcium-mediated signaling | 1 |
| regulation of calcium-mediated signaling | 1 |
| negative regulation of intracellular signal transduction | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| monoatomic cation homeostasis | 1 |
| inorganic ion homeostasis | 1 |
| tooth mineralization | 1 |
| amelogenesis | 1 |
| calcium ion transport | 1 |
| response to high light intensity | 1 |
| cellular response to light intensity | 1 |
| potassium ion transport | 1 |
| regulation of membrane potential | 1 |
| odontogenesis of dentin-containing tooth | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| monoatomic cation channel activity | 1 |
| calcium ion transmembrane transporter activity | 1 |
| calcium:sodium antiporter activity | 1 |
Protein interactions and networks
STRING
1439 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC24A4 | TPCN2 | Q8NHX9 | 914 |
| SLC24A4 | SLC45A2 | Q9UMX9 | 854 |
| SLC24A4 | OCA2 | Q04671 | 849 |
| SLC24A4 | ZCWPW1 | Q9H0M4 | 827 |
| SLC24A4 | RIN3 | Q8TB24 | 819 |
| SLC24A4 | NME8 | Q8N427 | 785 |
| SLC24A4 | TYR | P14679 | 733 |
| SLC24A4 | MC1R | Q01726 | 731 |
| SLC24A4 | ASIP | P42127 | 723 |
| SLC24A4 | CASS4 | Q9NQ75 | 720 |
| SLC24A4 | TYRP1 | P17643 | 714 |
| SLC24A4 | ABCA7 | Q8IZY2 | 706 |
| SLC24A4 | IRF4 | Q15306 | 701 |
| SLC24A4 | ODAPH | Q17RF5 | 696 |
| SLC24A4 | FERMT2 | Q96AC1 | 691 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC24A4 | MYL12B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (15): SLC24A4 (Affinity Capture-RNA), SLC24A4 (Affinity Capture-MS), SLC24A4 (Co-fractionation), SPON1 (Co-fractionation), VPS26A (Co-fractionation), ACTA2 (Affinity Capture-MS), ACTG1 (Affinity Capture-MS), CTSD (Affinity Capture-MS), GOLPH3 (Affinity Capture-MS), MYH10 (Affinity Capture-MS), MYL12B (Affinity Capture-MS), PUF60 (Affinity Capture-MS), TMOD3 (Affinity Capture-MS), TMX2 (Affinity Capture-MS), TPM4 (Affinity Capture-MS)
ESM2 similar proteins: A0A096X8J7, A3QM97, A7T1N0, B2RXE2, E9Q3M5, G3X939, G5EBK1, M5A7P9, O13726, O80739, P19334, P26432, P26433, P31662, P32847, P34586, P48764, P48994, P79100, Q01345, Q04121, Q09573, Q14940, Q1ZXJ0, Q28362, Q69RI8, Q6A4L1, Q6AI14, Q6H4R6, Q6RI88, Q84MS3, Q8BJI1, Q8BTY2, Q8BUE1, Q8CFW1, Q8NFF2, Q8T5S1, Q8VIH3, Q93380, Q94225
Diamond homologs: B8K1V7, O22252, O54701, P23685, P32418, P48765, P48766, P48767, P48768, P57103, P70414, P70549, Q01728, Q2R041, Q6H641, Q8BUN9, Q8CGQ8, Q8K596, Q8NFF2, Q99PD7, Q9EPQ0, Q9HC58, Q9UI40, Q9UPR5, Q9VDG5, Q9VN12, S4R2P9, F1NXU8, O04034, O16242, P87122, Q49SH1, Q6AXS0, Q71RS6, Q925Q3, Q9FKP1, Q9FKP2, Q9U6A0, O60721, O46383
SIGNOR signaling
3 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SLC24A4 | “down-regulates quantity” | calcium(2+) | relocalization |
| SLC24A4 | “down-regulates quantity” | potassium(1+) | relocalization |
| SLC24A4 | “up-regulates quantity” | sodium(1+) | relocalization |
Disease & clinical
Clinical variants and AI predictions
ClinVar
186 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 5 |
| Likely pathogenic | 0 |
| Uncertain significance | 98 |
| Likely benign | 27 |
| Benign | 41 |
Top pathogenic / likely-pathogenic (5)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1326286 | NM_153646.4(SLC24A4):c.613C>T (p.Arg205Ter) | Pathogenic |
| 139657 | NM_153646.4(SLC24A4):c.1015C>T (p.Arg339Ter) | Pathogenic |
| 139658 | NM_153646.4(SLC24A4):c.1495A>T (p.Ser499Cys) | Pathogenic |
| 139659 | NM_153646.4(SLC24A4):c.437C>T (p.Ala146Val) | Pathogenic |
| 689492 | NM_153646.4(SLC24A4):c.1192C>T (p.Gln398Ter) | Pathogenic |
SpliceAI
3959 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:92325861:A:AG | acceptor_gain | 1.0000 |
| 14:92433910:A:AG | acceptor_gain | 1.0000 |
| 14:92433910:AGC:A | acceptor_gain | 1.0000 |
| 14:92433911:G:GG | acceptor_gain | 1.0000 |
| 14:92433911:GC:G | acceptor_gain | 1.0000 |
| 14:92433911:GCG:G | acceptor_gain | 1.0000 |
| 14:92433987:GT:G | donor_gain | 1.0000 |
| 14:92442083:TTTCA:T | acceptor_loss | 1.0000 |
| 14:92442087:A:AG | acceptor_gain | 1.0000 |
| 14:92442087:AG:A | acceptor_loss | 1.0000 |
| 14:92442088:G:A | acceptor_loss | 1.0000 |
| 14:92442088:G:GG | acceptor_gain | 1.0000 |
| 14:92442088:GA:G | acceptor_gain | 1.0000 |
| 14:92442138:G:GT | donor_gain | 1.0000 |
| 14:92442170:ATTGG:A | donor_loss | 1.0000 |
| 14:92442171:TTGGT:T | donor_loss | 1.0000 |
| 14:92442173:GGTAA:G | donor_loss | 1.0000 |
| 14:92442174:G:GG | donor_gain | 1.0000 |
| 14:92442174:G:T | donor_loss | 1.0000 |
| 14:92442175:T:A | donor_loss | 1.0000 |
| 14:92442707:TTCCA:T | acceptor_loss | 1.0000 |
| 14:92442708:TCCA:T | acceptor_loss | 1.0000 |
| 14:92442709:CCA:C | acceptor_loss | 1.0000 |
| 14:92442710:CA:C | acceptor_loss | 1.0000 |
| 14:92442711:A:AG | acceptor_gain | 1.0000 |
| 14:92442711:AG:A | acceptor_gain | 1.0000 |
| 14:92442711:AGG:A | acceptor_gain | 1.0000 |
| 14:92442711:AGGG:A | acceptor_gain | 1.0000 |
| 14:92442712:G:GG | acceptor_gain | 1.0000 |
| 14:92442712:G:T | acceptor_loss | 1.0000 |
AlphaMissense
4085 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:92439393:T:C | L126P | 1.000 |
| 14:92442129:T:C | M145T | 1.000 |
| 14:92442130:G:A | M145I | 1.000 |
| 14:92442130:G:C | M145I | 1.000 |
| 14:92442130:G:T | M145I | 1.000 |
| 14:92442132:C:A | A146D | 1.000 |
| 14:92442134:G:C | A147P | 1.000 |
| 14:92442135:C:A | A147E | 1.000 |
| 14:92442137:G:A | G148R | 1.000 |
| 14:92442137:G:C | G148R | 1.000 |
| 14:92442138:G:A | G148E | 1.000 |
| 14:92442140:A:C | S149R | 1.000 |
| 14:92442142:C:A | S149R | 1.000 |
| 14:92442142:C:G | S149R | 1.000 |
| 14:92442150:C:A | P152Q | 1.000 |
| 14:92442150:C:G | P152R | 1.000 |
| 14:92442156:T:C | L154P | 1.000 |
| 14:92442752:T:A | I173N | 1.000 |
| 14:92442757:G:C | G175R | 1.000 |
| 14:92442757:G:T | G175C | 1.000 |
| 14:92442758:G:A | G175D | 1.000 |
| 14:92442758:G:T | G175V | 1.000 |
| 14:92442769:T:C | F179L | 1.000 |
| 14:92442771:C:A | F179L | 1.000 |
| 14:92442771:C:G | F179L | 1.000 |
| 14:92442774:C:A | N180K | 1.000 |
| 14:92442774:C:G | N180K | 1.000 |
| 14:92443431:G:C | R205P | 1.000 |
| 14:92443433:G:C | D206H | 1.000 |
| 14:92443434:A:C | D206A | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000005176 (14:92469375 G>C,T), RS1000009832 (14:92323011 G>A,C,T), RS1000051723 (14:92360384 T>A), RS1000053802 (14:92454316 A>G), RS1000059066 (14:92473690 C>G), RS1000074746 (14:92354048 C>A,T), RS1000086645 (14:92430721 C>T), RS1000090826 (14:92354849 G>A,T), RS1000132834 (14:92475687 G>A), RS1000163225 (14:92392636 G>A), RS1000188817 (14:92430481 C>T), RS1000195014 (14:92338764 C>T), RS1000195688 (14:92437262 C>G,T), RS1000200979 (14:92421019 T>C), RS1000219831 (14:92412818 A>G)
Disease associations
OMIM: gene MIM:609840 | disease phenotypes: MIM:104500, MIM:615887
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| amelogenesis imperfecta hypomaturation type 2A5 | Strong | Autosomal recessive |
| amelogenesis imperfecta, type 3A | Supportive | Autosomal dominant |
| amelogenesis imperfecta type 2 | Supportive | Autosomal recessive |
Mondo (4): amelogenesis imperfecta (MONDO:0019507), amelogenesis imperfecta hypomaturation type 2A5 (MONDO:0014385), amelogenesis imperfecta, type 3A (MONDO:0007538), amelogenesis imperfecta type 2 (MONDO:0015048)
Orphanet (1): Amelogenesis imperfecta (Orphanet:88661)
HPO phenotypes
7 total (7 of 7 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000670 | Carious teeth |
| HP:0000705 | Amelogenesis imperfecta |
| HP:0001595 | Abnormal hair morphology |
| HP:0002164 | Nail dysplasia |
| HP:0006286 | Yellow-brown discoloration of the teeth |
| HP:0011463 | Childhood onset |
GWAS associations
38 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000117_1 | Blue vs. green eyes | 4.000000e-38 |
| GCST000118_1 | Blond vs. brown hair color | 1.000000e-48 |
| GCST000190_1 | Black vs. blond hair color | 8.000000e-21 |
| GCST000707_2 | Hair color | 5.000000e-13 |
| GCST000710_3 | Eye color | 2.000000e-23 |
| GCST000710_5 | Eye color | 1.000000e-16 |
| GCST001066_12 | Dialysis-related mortality | 8.000000e-06 |
| GCST001066_5 | Dialysis-related mortality | 2.000000e-06 |
| GCST001929_6 | Eye color | 4.000000e-11 |
| GCST001929_8 | Eye color | 3.000000e-07 |
| GCST001932_4 | Hair color | 2.000000e-36 |
| GCST002245_20 | Alzheimer’s disease (late onset) | 6.000000e-09 |
| GCST002817_14 | Alzheimer’s disease in APOE e4- carriers | 4.000000e-07 |
| GCST003021_5 | Brown vs. non-brown hair color | 3.000000e-09 |
| GCST003022_5 | Light vs. dark hair color | 3.000000e-10 |
| GCST003023_4 | Blond vs non-blond hair color | 3.000000e-10 |
| GCST003996_30 | Monobrow | 4.000000e-21 |
| GCST005790_32 | Rosacea symptom severity | 5.000000e-06 |
| GCST005965_3 | B cell acute lymphoblastic leukaemia (normal cytogenetics) | 6.000000e-09 |
| GCST005966_3 | B cell acute lymphoblastic leukaemia (hyperdiploid negative) | 2.000000e-06 |
| GCST005967_3 | B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative) | 3.000000e-06 |
| GCST006075_19 | Hair color | 1.000000e-100 |
| GCST006988_117 | Blond vs. brown/black hair color | 1.000000e-09 |
| GCST006988_130 | Blond vs. brown/black hair color | 9.000000e-15 |
| GCST006988_142 | Blond vs. brown/black hair color | 9.000000e-13 |
| GCST006989_38 | Brown vs. black hair color | 3.000000e-128 |
| GCST007319_25 | Alzheimer’s disease (late onset) | 1.000000e-07 |
| GCST007319_28 | Alzheimer’s disease (late onset) | 2.000000e-08 |
| GCST007320_75 | Alzheimer’s disease or family history of Alzheimer’s disease | 2.000000e-10 |
| GCST007320_94 | Alzheimer’s disease or family history of Alzheimer’s disease | 2.000000e-07 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003949 | eye color |
| EFO:0003924 | hair color |
| EFO:0007906 | synophrys measurement |
| EFO:0009180 | rosacea severity measurement |
| EFO:0009268 | family history of Alzheimer’s disease |
| EFO:0004611 | low density lipoprotein cholesterol measurement |
| EFO:0006834 | septic shock |
| EFO:0004530 | triglyceride measurement |
| EFO:0007984 | platelet component distribution width |
MeSH disease descriptors (3)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D000567 | Amelogenesis Imperfecta | C07.650.800.295.250; C07.793.700.295.250; C16.131.850.800.295.250 |
| C536606 | Amelogenesis Imperfecta hypomaturation type (supp.) | |
| C562880 | Amelogenesis Imperfecta, Type III (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5209636 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs77441273 | SLC24A4 | 0.00 | 0 |
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC24 family of sodium/potassium/calcium exchangers
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, increases mutagenesis | 2 |
| bisphenol A | decreases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| arsenite | decreases methylation | 1 |
| pentanal | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Environmental Pollutants | affects expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Zidovudine | affects cotreatment, increases expression | 1 |
| 1-Methyl-4-phenylpyridinium | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 functional
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5209621 | Functional | Substrate uptake by the Sodium/Potassium/Calcium Exchanger 4 (NCKX4, SLC24A4) as assessed by Screen Questtrade mark Fluo-8 NW calcium assay kit in HEK-293 JumpIN-SLC24A4 cells (PubChem AID: 1794814) | Fluo-8 based assay for SLC24A4 using HEK293 JumpIn SLC24A4 OE cells |
Clinical trials (associated diseases)
8 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT01746121 | Not specified | TERMINATED | Amelogenesis Imperfecta |
| NCT02994862 | Not specified | UNKNOWN | E. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent |
| NCT03810859 | Not specified | UNKNOWN | Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants |
| NCT04704089 | Not specified | RECRUITING | Colorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects |
| NCT04897724 | Not specified | UNKNOWN | Clinical Performance of Composites in Patients With Amelogenesis Imperfecta |
| NCT04927962 | Not specified | COMPLETED | Psycho-social Impact of Amelogenesis and Dentinogenesis Imperfecta |
| NCT05343247 | Not specified | COMPLETED | Dental Age Estimation by Different Methods in Patients With Amelogenesis Imperfecta |
| NCT07250906 | Not specified | RECRUITING | Oral Health Related Quality of Life of Children With Amelogenesis Imperfecta |
Related Atlas pages
- Associated diseases: amelogenesis imperfecta hypomaturation type 2A5, amelogenesis imperfecta, type 3A, amelogenesis imperfecta type 2
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Alzheimer disease, amelogenesis imperfecta, amelogenesis imperfecta hypomaturation type 2A5, amelogenesis imperfecta type 2, amelogenesis imperfecta, type 3A, B-cell acute lymphoblastic leukemia, chronic kidney disease, cutaneous melanoma